Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
AMER. ZOOL., 19:163-174 (1979). FMRFamide, a Cardioexcitatory Neuropeptide of Molluscs: An Agent in Search of a Mission MICHAEL J. GREENBERC AND DAVID A. PRICE Department of Biological Sciences, Florida State University, Tallahassee, Florida 32306 SYNOPSIS. Aqueous extracts of molluscan ganglia have cardioexcitatory activity that is not attributable to the usual neurohumors: 5-hydroxytryptamine, acetylcholine or dopamine. Morphological, physiological and biochemical studies have suggested that this cardioexcitation is caused by a handful of unidentified neurohormones, mostly polypeptides. One of the active components of extracts of the pooled central ganglia of Macrocallista nimbosa (Bivalvia) has now been isolated, purified, characterized and synthesized. This substance, previously designated peak C, is a tetrapeptide amide: phenylalanyl-methionyl-arginylphenylalanine amide (Phe-Met-Arg-Phe-NH2; FMRFamide). Low concentrations of FMRFamide (threshold: 10~9-10~8M) induce rhythmical activity in isolated quiescent bivalve hearts and augment the force and frequency of contraction of those already beating. The peptide also produces contractures of non-cardiac molluscan muscles, including especially the radula protractor of the whelk, Busycon contrarium, a sensitive assay object. The effects of FMRFamide on Mercenaria mercenaria hearts appear to be mediated by adenosine 3', 5'-monophosphate (cycwic AMP). Peak C activity occurs in all species tested in all the major molluscan classes; but we do not yet know whether all Peak C's are FMRFamide. That FMRFamide is a neurosecretory product has still to be established, and its normal physiological role in molluscs has yet to be defined. Nevertheless, we suppose that, together with other neuropeptides, FMRFamide is released into the hemolymph to provide long-term maintenance and regulation of tone, rhythmicity and excitability of visceral muscle. cology has been reviewed by Greenberg et al., 1973.) Intractably hypodynamic prepaThe most fundamental characteristic of rations frequently respond to an aqueous cardiac muscle is its spontaneous rhythmiof pooled ganglia. extract cal activity. The rhythmicity of the myoReports that molluscan ganglion extracts genic hearts of molluscs, tunicates, verteor contractions produce cardioexcitation brates and insects, arises in the muscle and that these efof non-cardiac muscle, itself and usually continues when the myocardium, or a portion of it, is suitably iso- fects are not attributable to the usual mollated in an appropriate saline medium. Yet, luscan neurohumors — acetylcholine (ACh), in the course of surveying the pharmacol- 5HT, or dopamine—have been accumuogy of bivalve hearts (e.g., Greenberg, 1965, lating for about two decades; the observa1969), we have found that some prepara- tions come from species representing every tions (and in some species, all preparations) molluscan Class except Scaphopoda (sumbecome arrhythmic in vitro. Among vari- marized by Greenberg et al., 1973). The ous treatments, use of the molluscan car- unidentified excitor, at first referred to as dioexcitatory neurotransmitter, 5-hy- "Substance X" (Hill and Welsh, 1966), was droxytryptamine (5HT), often induces soon shown to be composed of from three beating in quiescent hearts; often it does to five chromatographically separable ennot. (The alchemy of oscillogenic pharma- tities; the number depended upon the particular species examined (Frontali et at, 1967; Agarwal et al., 1972). Three of the This work was supported by NIH Grant HL-09283 to MichaelJ. Greenberg. This is Contribution No. 100 active agents (designated peaks A, B and INTRODUCTION from the Tallahassee, Sopchoppy and Gulf Coast C) from Mercenaria mercenaria ganglion Marine Biological Association. We acknowledge the help of Association members in collecting and dis- extracts proved to be peptides (Frontali et secting the thousands of clams used in the studies al., 1967). reported here. Peak C, alone, has been detected in the 163 164 MICHAEL J. GREENBERG AND DAVID A. PRICE nervous tissue extracts of every species investigated (Greenberg et al., 1973). Moreover, although it is highly concentrated in the ganglia, peak C activity is also widely distributed in other tissues of the dried ganglia dissected from 500 clams yields about 5 nanomoles of FMRFamide; i.e., the pooled ganglia from one clam contain about 10 picomoles. FMRFamide was synthesized, and was then purified by the same techniques used bivalve, Macrocallistu nimbosa (Agarwal et al., 1972). Finally, while all of the active in the purification of the natural peptide. substances increase the force of contrac- Synthetic and natural FMRFamide gave tion and frequency of normally beating identical thin-layer chromatograms. The hearts, only peak C also induces beating in biological effects of the natural and synhypodynamic myocardia (Agarwal and thetic materials were qualitatively and quanGreenberg, 1969). Because of its ubiquity, titatively indistinguishable, whether they distribution in molluscan tissues, and an- were tested on the clam heart or the radula tiarrhythmic action, we began the process protractor (details of purification, characof identifying peak C. Recently we suc- terization and synthesis in Price and Greenberg, 1977a,6). ceeded (Price and Greenberg, \977a,b). In retrospect we can see that the purification of FMRFamide was facilitated by PURIFICATION AND CHARACTERIZATION its composition. FMRFamide is a strong Sun-ray venus clams, Macrocallista nim- base due to the guanidino group of its arbosa, were collected in batches of 800 to ginyl residue; but it is also non-polar due 1,000 (ten bushels) from St. Joseph Bay to its other three residues. Most substances, near Apalachicola, Florida. The cerebral, including impurities, have only one or the pedal and visceral ganglia were dissected other of these two properties. Therefore, out, pooled, and lyophilized. The peak C by using separative procedures exploiting, activity was purified by the combined use in turn, its basic and non-polar characterof solvent extractions, gel filtration and istics, FMRFamide could be isolated in relion-exchange chromatography. During atively pure form in a small number of purification, activity was monitored with a steps. parallel bioassay system consisting of the radula protractor muscle of the whelk BusyPHARMACOLOCY con contrarium, and the heart of the clam Mercenaria mcrcenaria. T h e responses of these preparations are discussed below. Purified peak C has a phenylalanine-like absorption spectrum and an isoelectric point greater than pH 10. It is inactivated by trypsin, chymotrypsin and Pronase, and gives a positive reaction with both ninhydrin and the Sakaguchi reagent for arginine. Its amino acid composition is Phe2.oo Metfl.mArg, 12. On the basis of N-terminal analysis, Edman-dansyl degradation and tryptic digestion, the structure was found to be that of a tetrapeptide amide: PheMet-Arg-Phe-NH2. (We call the peptide FMRFamide since F, M and R are the approved one-letter abbreviations for phenylalanine, methionine and arginine, respectively. The designation thus conveys both the amino acid sequence and the substitution of the carboxy terminal. And it is a euphonious partial acronym.) One gram of The parallel bioassay The Mercenaria heart and the Busycon radula protractor muscle are both classical assay objects whose isolation, preparation and pharmacological characteristics have long been studied (Welsh and Taub, 1948; Hill, 1958). The effect of FMRFamide on the radula protractor is a sustained contraction; threshold is 1-3 x 10"9 M. ACh, the presumed excitatory neurotransmitter, has the same effect, but is antagonized by prior treatment with benzoquinonium chloride (BQ). FMRFamide contractures are not affected by BQ. Other indolealkylamines, as well as 5 HT, and catecholamines either relax the protractor muscle or have no effect; the particular response depends upon the resting tension. If a protractor is in ACh contracture, addition of 5HT relaxes the NEUROPEPTIDE CARDIOEXCITATION IN MOLLUSCS muscle and induces rhythmical contractions (Hill, 1958). FMRFamide contractures are reduced in the presence of 5HT. FMRFamide increases the amplitude of beat of active Mevcenaria hearts and induces beating in quiescent preparations; threshold is 1-2 x 10~8 M. The effect is similar, qualitatively and quantitatively to that of 5HT, but is not blocked by the 5HT antagonist, methysergide (UML). In contrast to its effect on the radula protractor, ACh inhibits the beat of the Mercenaria heart, and even very low concentrations (10~ 9 10~8 M) cause arrest. Since FMRFamide excites both the radula protractor and the clam heart, and since these effects are not blocked by either of the appropriate inhibitors, BQ or UML, in neither preparation can the peptide be acting by releasing 5HTor ACh. A set of tetra-r tri- and dipeptide analogs of FMRFamide has been synthesized; all contain various permutations of the same three amino acids as are found in the parent compound. These peptides, the constituent amino acids themselves, and three additional arginine derivatives (benzoyl arginine, benzoyl arginine amide and tosyl arginine amide), were all tested on the protractor muscle. Of all these compounds, only Phe-Met-Arg-Phe-OH and Met-ArgPhe-NH2 had any activity at all; and the relative potencies were no better than, respectively, 1/100 and 1/1000 that of FMRFamide (Table 1). Thus, the biological acTABLE 1. Structure-activity relations of FMRFamide on Busycon contrarium radula protractor." Peptide Phe-Met-Arg-Phe-NH., (FMRFamide) Phe-Met-Arg-Phe-OH Phe-Met-Phe-Arg-NH., Phe-Met-Phe-Arg-OH Mei-Arg-Phe-NH2 Phe-Met-Arg-NH., Arg-Phe-NH., Phe-Arg-OH Met-Arg-NH2 d Relative potency" 1.00 .01 c — .001 — — — — Data from Price and Greenberg, 1977a. Relative effect of a threshold dose of FMRFamide (3x10 » M ) = 1.00. '• No effect up to, and including, 10"' M. 11 165 tivity of FMRFamide appears to depend on the arrangement of its four constituent amino acid residues in the specific sequence determined. Possible mechanisms of FMRFamide cardioexcitation The effect of FMRFamide on the electrical properties of the molluscan myocardium have been examined only in a preliminary experiment. Partially purified Macrocallista peak C induced regular, rhythmic spiking and mechanical activity in quiescent Modiolus hearts; the membrane potential was not affected (Wilkens and Greenberg, 1973). The ability of thyrotropin-releasing hormone (TRH) to induce repetitive calcium spikes in cultured anterior pituitary cells (Taraskevich and Douglas, 1977) is in striking parallel with the effect of FMRFamide on bivalve heart muscle. Previous studies in our laboratory had suggested that the cardioexcitatory action of 5HT on the heart of Mercenaria was mediated by cyclic AMP (Higgins, 1974; Higgins and Greenberg, 1974). Recently, therefore, we returned to consider the effect of FMRFamide on adenylate cyclase activity and cyclic AMP concentration in Mercenaria ventricles, and to compare these effects to those of 5HT (Higgins et al., 1978). In summary, hearts treated with either 5HT or FMRFamide showed an increase in adenylate cyclase activity and an elevation in cyclic AMP concentration. These effects were dependent on dose and the duration of treatment. The rate of increase of cyclic AMP concentration is as fast as the rate of development of the positive inotropic effect. While the effect of 5HT is blocked by UML, that of FMRFamide is not; thus these two substances act at different receptor sites. The independence of action of 5HT and FMRFamide was recently pursued by Higgins (1977), starting with the old observation (Greenberg, 1960) that high concentrations of 5HT first excite the isolated ventricle of Mercenaria and then specifically desensitize it to further additions of 166 MICHAEL J. GREENBERG AND DAVID A. PRICE the neurohumor. Higgins demonstrated that this 5HT-induced tachyphylaxis includes both the desensitization of the myocardial adenylate cyclase and a reduced increase in intracellular cyclic AMP. However, FMRFamide can still increase the contractility, adenylate cyclase activity and cyclic AMP concentration of a ventricle that is tachyphylactic to 5HT. Thus, while FMRFamide and 5HT appear to share a common mechanism of action, the two agonist-receptor interactions initiating this mechanism, must occur at different sites on the cell membrane. The actions of FMRFamide on other molluscan muscles Recently, we have been surveying the effects of FMRFamide on selected molluscan muscle preparations. First, the isolated hearts from a number of species of bivalves, including Mytilus edulis, Chione cancellata, Crassostrea virginica and Modiolus demissus, were tested. Invariably, the effect of FMRFamide is excitatory: an increase in amplitude, frequency or both. That this response should also be characteristic of all M. demissus hearts is of interest since 5HT may depress or excite individual preparations from this species (Fig. 1 A). Thus, the mimicry of 5HT by FMRFamide on molluscan myocardium is not general. Furthermore, the adenylate cyclase activity of M. demissus hearts is very low (Higgins, 1974). Consequently, FMRFamide excitation may be mediated by other intracellular mechanisms; certainly, this seems to be occurring in the case of Modiolus heart. FMRFamide causes the anterior byssus retractor muscle (ABRM) of Mytilus edulis to go into "catch." That is, a suitable dose of the peptide produces a sustained contracture, and the muscle relaxes only slowly even after the FMRFamide is washed out of the bath. The rate of relaxation is markedly increased by 5HT (Fig. I B). Thus, the effect of FMRFamide on the ABRM, as on the radula protractor, resembles that of ACh rather than 5HT. It follows that, since the effect of 5HT on the ABRM is apparently mediated by cyclic AMP (reviewed by Twarog, 1976), the mechanism of action of FMRFamide on this muscle must be different. Finally, two visceral muscles have been challenged with FMRFamide: the rectum of Macrocallista, and the esophagus of the prosobranch gastropod, Fasciolaria tulipa. FMRFamide induces rhythmic activity in both muscles; the response is especially marked in the esophagus (Fig. 1C). Again, 5HT cannot induce rhythmicity in a quiescent preparation, and actually inhibits such activity when it is present (Fig. 1C). In summary, while 5HT and ACh are notable for the variability of their pharmacological effects {e.g., Greenberg, 1969), FMRFamide appears to be uniformly excitatory. However, other mechanisms, in addition to augmentation of adenylate cyclase activity, will probably be found to underlie these effects. Finally, FMRFamide has been dutifully tested on isolated cardiac and vascular muscle of rat (Price and Lipner, personal communication) and guinea pig ileum (Higgins, personal communication). Such small effects as were observed, occurred only at very high concentrations. Conversely, we have also tested, on the Mercenaria heart and the Busycon radula protractor: Substance P, eledoisin, physalaemin, oxytocin, vasopressin and the C-terminal tetrapeptide of gastrin. All were inactive in bath concentrations up to 0.1 mM. DISTRIBUTION Are all peak C's FMRFamide? The identity of all peak C's follows from the observation that: if the pooled ganglia of any mollusc are extracted and purified according to a defined protocol, a predictable, limited elution volume from the final get filtration will produce a characteristic excitation, including the induction of rhythmicity, when assayed on the isolated heart of a venerid bivalve (Agarwal et «/., 1972). The number and diversity of molluscs already tested is sufficiently large, and the procedure leading to the result is sufficiently involved, that mere coincidence appears unlikely. However, faced with the apparent difference between the egg-lay- B t F °8 5xlO"°M 5HT IO"6M FIG. I. Effects of FMRFainide (Fa) and 5-hydroxytryptamine (5HT) on isolated molluscan muscles. Drugs are added to the supervision medium at the upward-pointing arrows, and doses are expressed as concentrations in the organ bath. A) Ventricles of Modiolus demissus. Upper and lower records are from different preparations. The baths were washed out after the 5HT response and before the addition of FMRFamide. B) Anterior byssus retractor muscle (ABRM) of Mytilus edulis. Downward-pointing arrow Fa IO"8M indicates washout of the organ bath. C) Esophagus of Fasciolaria tulipa. Upper and lower records are from the same preparation; doses of 5HT and FMRFamide were repeated. The bath was washed after the first 5HT response; but the second dose of FMRFamide was not washed out before 5HT was added. Time bar: I min. Temperature: A, C, 2I°C; B, 16°C. (Price, Painter, Klausman and Greenberg, unpublished observations.) 168 MICHAELJ. GREENBERG AND DAVID A. PRICE ing hormones of Aplysia and Pleurobran- FMRFamide were the product of such a chaea (Ram et al., 1977), a healthy skepti- process, then peaks A or B, or the molluscism about the identity of all peak C's with can reproductive hormones, might be deFMRFamide is essential until the identity rived from the same large precursor. Howhas been conclusively demonstrated. ever, in the absence of any corroborative, especially chemical, data, further speculation would be gratuitous. FMRFamide and other molluscan neuropeptides might be homologous A number of molluscan neuropeptides have, by now, been identified, but not chemically characterized (Table 2; reviewed by Frontali and Gainer, 1977). Their known effects are defined by their assays and therefore reflect, primarily, the interests of the laboratories where they are studied. However, by analogy with both crustacean (e.g., Mordue and Stone, 1977) and vertebrate (reviewed by Wallis, 1975) hormones, any of these peptides could have additional actions on other systems in the same animal, or in other molluscs. The acquisition of new functions in different molluscan groups could have been accompanied by relatively small changes in the amino acid composition. Consequently, FMRFamide might be homologous, or even identical, to one or more of the factors, all chemically uncharacterized, listed in Table 2. But is it? Data by which the molluscan peptides might be chemically distinguished comprises a scattering of sensitivities to proteolytic enzymes and some molecular weights obtained from gel filtration (Table 2). On the basis of their lack of sensitivity to trypsin and chymotrypsin, neither the cardioexcitatory neurosecretory substance (NS) from cephalopod vena cava, nor the various bursting pacemaker potential (BPP) inducers isolated from extracts of gastropod ganglia or their constituent cells (references in Table 2), are likely to be related to FMRFamide. Since it co-chromatographs with peak C, FMRFamide cannot be identical with peaks A or B. Moreover, the molecular weight proposed for the reproductive neuropeptides is about ten times higher than that of FMRFamide (Table 2). However, many hormones, including neuropeptides, may be produced by the action of specific proteolytic enzymes on high molecular weight precursors (reviewed by Gainer et al., 1977). If The possibility that FMRFamide occurs and is functional in other phyla The possible polyphyletic distribution of FMRFamide is best considered as part of the larger problem: the degree of homology between the arrays of neuropeptides characteristic of each phylum. A definitive solution would require that the chemical structures of at least most of the neuropeptides in three or four phyla be known. In fact, they are mostly unknown except in the class Vertebrata where between 15 and 20 neuropeptides have been chemically identified and localized (references in Zettler, 1976; Brownstein, 1977; Robberecht et al., 1978). In contrast, of about 30 arthropod neuropeptides listed by Frontali and Gainer (1977), only 4 are chemically identified (Fernlund and Josefsson, 1972; Stone rf al., 1976; Fernlund, 1976; Brown, 1975; Brown and Starratt, 1975; Starratt and Brown, 1975). And in the molluscs, only about 13 neuropeptides have so far been characterized (Table 2); some of these may be chemical homologs, but only FMRFamide is known. Even with the paucity of information, we can still make the argument that there is little or no homology between the neuropeptides of evolutionarily disparate phyla. Firstly, there is little chemical similarity between FMRFamide, any of the known arthropod neuropeptides, and those of vertebrates. Kleinholz (1976), for example, noted the dissimilarity between the distal retinal pigment hormone (DRPH) and the seven amino acid sequence required for vertebrate peptides to have MSH-like activity. Secondly, in many instances where it has been sought, cross-reactivity has not been found. This was our experience, described above, with FMRFamide and a number of vertebrate peptides. For another example, the absence of enkephulin acthity NEUROPEPTIDE CAROIOEXCITATION IN MOLLUSCS and opiate receptor binding in the nervous systems of clams, as well as various types of arthropods and planarians, has been shown (Simantov et al., 1976). Nevertheless, the following evidence suggests that the notion of lack of homology should be viewed with caution. Firstly, two vertebrate neuropeptides have been found in molluscs. Immunoreactive gastrin, recently demonstrated in vertebrate brain (Vanderhaeghen et al., 1975), also occurs in gastropod blood and gut — but not brain (Straus et al., 1975). And immunoreactive TRH was located in the circumesophageal ganglia of gastropods (Grimm-j0rgensen et al., 1975). However, these identifications, based only on radioimmunoassay, should be confirmed by standard biological analyses {e.g., Skelley^a/., 1973). Secondly, eledoisin, a toxin occurring in the posterior salivary glands of cephalopods, is an analog of the vertebrate neuropeptide, Substance P; both are undecapeptides with similar carboxy terminals: -Phe-(Ile or Phe)-Gly-Leu-Met-NH2 {e.g., Leeman et al., 1977). That molluscan tissues can manufacture a Substance P-like peptide is provocative; but eledoisin has not yet been found in molluscan nerve cells. Finally, low concentrations of vasopressin and oxytocin initiate bursting pacemaker potential (BPP) activity in particular cells of gastropod ganglia (reviewed by Barker, 1977; Levitan and Treistman, 1977), and increase cyclic AMP levels in Helix ganglion homogenates (Levitan and Treistman, 1977). In these effects, the neurohypophysial hormones are mimicking the actions of peptides which occur in crude ganglion extracts of these species (Table 2). The endogenous peptides are not oxytocin or vasopressin (Ifshin et al., 1975; supported by data of Levitan and Treistman, 1977). Moreover, neither oxytocin nor vasopressin has been demonstrated in molluscan tissues. PHYSIOLOGICAL ROLE Is F'MRFamide a product oj' neurosecretion? We have been assuming throughout this 169 discussion that, since FMRFamide (or peak C) is concentrated in nervous tissue, it is probably a neurosecretory product, stored in membrane vesicles and released, either from the ganglia, or from peripheral sites of innervation, particularly the heart. This notion is supported primarily by cytological observations; but some experimental evidence can also be adduced. Firstly, the cardiac innervation in a number of pulmonate gastropods has been examined by transmission electron microscopy (Helix pomatia: Cottrell and Osborne, 1969; four species of achatinids: Nisbet and Plummer, 1966; 1969; Helisoma tenue and Helix aspersa: Simpson, 1969; Lymnaea stag- nalis: Plesch, 1977). These investigations showed, in sum, that only the auricles of pulmonate hearts are heavily innervated and especially in the region close to the auriculo-ventricular junction. Furthermore, many of the axons in this region terminate adjacent to the cardiac lumen. Visible in at least some of the nerve terminals are uniformly granulated vesicles (100-250 nra) which, on the basis of fluorescence microscopy, contain neither 5HT nor dopamine. The consensus is that these are neurosecretory granules. Cottrell and Osborne (1969) suggested that the auriculo-ventricular junctions function as neurohemal organs; their notion was supported by Nisbet and Plummer (1969); and Plesch (1977) found axon terminals in Lymnaea heart containing granules similar to those in particular neurosecretory cells of the visceral and parietal ganglia. Recently, large, opaque vesicles were also observed in some nerve endings in the auriculo-ventricular region of the heart of the clam, Katelysia rhytiphora (Sathananthan and Burnstock, 1976). That these vesicles do not contain 5HT, ACh or dopamine was demonstrated; but the proposal that they release an ATPlike agent remains problematical. Crude extracts of snail auricles do, in fact, have cardioexcitor activity (reviewed by Greenberg et al., 1973); and extracts of Strophocheilus oblongus auricles (more than ventricles) induce rhythmical activity in isolated penis retractor muscles of this pulmonate (Jaeger, 1966). Finally, Cottrell (1966) and Cottrell and Maser (1967) car- TABLE 2. Molluscan neuropeptides through 1977. Designation HEART AND MUSCLE FMRFamide Peak Ca PeakB Source" Pooled ganglia (M (Macrocallista nimbosa) Pooled molluscan ganglia and heart Assay6 Effect" NS MW (daltons) 597.75 Bivalve Cardioexcitaheart; tion; muscle Busycon contraction; adenylate cyradula protractor m. 1 clase stimulation (only) FMRFamide) Isolated heart Cardioexci(Merce• tation. nana) Reference Price and Greenberg, 1977* < 1,500 Frontali et. al., 1967 < 1,500 Frontali and Gainer, 1977 > 1,500 Peak A „ F II Effect of proteolytic enzymes0 ChymoTrypsin trypsin Pepsin Pronase Papain CEG (Stro- Isolated ven- Cardioexciphocheilus tricle (Strotation. oblongus) phocheilus) Isolated sysLong-lasting Vena cava ant NS temic heart cardioexcisystem (Octopus) tation. (Cephalopoda) NERVOUS ACTIVITY PE CEG (Helve Neurone Fl pomatia) (Helix, RPaG) Long-duration BPP activn; cAMP accum; adenylate cyclase stimulation. CEG (Otala Cell 11 (Otala, Long-duration lactea) RPaG) BPP activn. Agarwal, etal., 1972 700-1,500 Hampe, etal., 1969 -1,300 Blanchi etal., 1973 700-5,000 Treistman and Levitan, 1976 Levitan and Treistman, 1977 700-5,000 Ifshin et al., 1975 Bag cells (Aplysia AbG) R 15 , L 1 0 (via I BPP induced & L3 & RB) augmented; (Aplysia AbG) { EPSP (not IPSP) ampl.increased. Cell 11 (Otala) Long-duration BPP activated. [- Mayeri and Simon, 1975 Barker, 1977 700-5,000 Ifshin etal., 1975 SALT AND WATER BALANCE — /?is (Aplysia AbG) REPRODUCTION Egg-laying hormone Bag cells (Aplysia AbG) Egg-laying hormone PeG medial lobe (Pleurobranchaea califor- nica) Egg capsule-laying PaOCPIG (Busycon substance canaliculatum; B. carica) n Injection into Osmotically hemocoel independent (Aplysia weight californica) increase. 1,500-30,000 Kupfermann and Weiss, 1976 Injection into Egg-laying; mature long-term Aplysia behavorial modification 6,000 Injection into Egg-laying; mature long-term Pleurostereotyped branchaea behavior. Injection into Laying unfilled mature egg capsules. female Toevs and Brackenbury, 1969; Arch, 1976 Arch and Smock, 1977 4,000-7,000 Ram etal., 1977 Ram, 1977 Busycon All peak C's have not been shown to be FMRFamide. Abbreviations: AbG (abdominal, or parietovisceral, ganglion); BPP (bursting pacemaker potential); CEG (circumesophageal ganglion or ring); CP1G (cerebropleural ganglion); EPSP (excitatory postsynaptic potential); IPSP (inhibitory PSP); NS (neurosecretory); PaG (partial ganglion); PeG (pedal ganglion); R15, L10, C, RB (identified cells in Aplysia AbG). c (+) enzyme destroys biological activity, (+ + , + + +) indicates relative effectiveness; (-) tested, but not effective; no entry: not tested. b 172 MICHAEL J. GREENBERG AND DAVID A. PRICE ried out a subcellular fractionation of Mercenaria ganglia and found a peak of cardioexcitatory activity, distinguishable from that of 5HT, and associated with uniformly granulated vesicles 100-300 nm in diameter. Since Cottrell's studies were completed before Substance X was resolved into its component activity peaks, we cannot be sure that FMRFamide was one of the agents associated with the observed vesicles. At present, about 10 cardioexcitor substances, including peptides and non-peptides, have been extracted from molluscan nervous tissues and characterized (Table 2; Frontali and Gainer, 1977; Agarwal et al., 1972). At the same time, and considering only pulmonates, about 10 or 11 kinds of neurosecretory cells have been distinguished by cytological techniques in the central ganglia (e.g., Boer et al., 1977; comparative review by Boer and Joosse, 1975); and there are about 7 types in peripheral structures, two of them in the heart (Plesch, 1977; Lymnaea). In no instance has any characterized cardioexcitory peptide been associated unequivocally with a particular neurosecretory vesicle, either central or peripheral. In summary, the status of FMRFamide as a neurosecretory product, while probable, is unproven. Possible functions J. H. Welsh suggested that neurosecreted polypeptides might act as long-duration, long-range mimics of the short-acting neurotransmitters (Welsh, 1955). Since FMRFamide and 5HT have similar effects on the heart of Mercenaria mercenaria, and since the two substances share a common intracellular mechanism of action mediated by an increased concentration of cyclic AMP (Higgins, 1977; Higgins et al., 1978), this system would appear to be a paradigm of Welsh's proposal. However, even our preliminary survey of FMRFamide pharmacology points to an essential difference between its actions and those of 5HT and the other neurotransmitters: FMRFamide lacks the versatility, characteristic of neurohumors; its effect is always excitatory. In that e\ent, the amount of FMRFainide re- leased into the circulating hemolymph, or possibly delivered by neural transport to peripheral sites, would determine the general level of excitability of visceral muscles in a mollusc, and this might be its role. However, we have been focussing on FMRFamide's stimulation of muscle merely because this is our method of assay. As discussed above, analogous evidence from other phyla implies that FMRFamide or a homolog might have additional targets in molluscs. Therefore, the physiological role of FMRFamide must remain obscure until the full range of its effects, its distribution within the organism and its variation with the condition of the animal — all presently unknown — have been investigated. REFERENCES Agarwal, R. A. and M. J. Greenberg. 1969. A comparative study of cardioactive agents from bivalve tissue. Comp. Biochem. Physiol. 31:835-850. Agarwal, R. A., P. J. B. Ligon, and M. J. Greenberg. 1972. The distribution of cardioactive agents among molluscan species and tissues. Comp. Gen. Pharmacol. 3:249-260. Arch, S. 1976. Neuroendocrine regulation of egg laying in Aplysia californica. Amer. Zool. 16:167-175. Arch, S. and T. Smock. 1977. Egg-laying behavior in Aplysia californica. Behav. Biol. 19:45-54. Barker, J. L. 1977. Physiological roles of peptides in the nervous system. In H. Gainer (ed.), Peptides in neurobiology, pp. 295-343. Plenum Press, New York. Blanchi, D., L. Noviello, and M. Libonati. 1973. A neurohormone of cephalopods with cardioexcitatory activity. Gen. Comp. Endocrinol. 21:267-277. Boer, H. H. and J. Joosse. 1975. Endocrinology. In V. Fretter and J. Peake (eds.), Pulmonates, Volume I. Functional anatomy and physiology, pp. 245-307. Academic Press, New York. Boer, H. H., E. W. Roubos, H. van Dalen, and J. R. F. Th. Groesbeek. 1977. Neurosecretion in the ba- • sommatophoran snail Bulinus truncatus (Gastropoda, Pulmonata). Cell Tiss. Res. 176:57-67. Brown, B. E. 1975. Proctolin: A peptide transmitter candidate in insects. Life Sci. 17:1241-1252. Brown, B. E. and A. N. Starratt. 1975. Isolation of p'roctolin, a myotropic peptide, from Periplaneta amencana.]. Insect Physiol. 21:1879-1881. Brownstein, M. J. 1977. Biologically active peptides in the mammalian central nervous system. In H. Gainer (ed.), Peptides in netirobwlogy, pp. 145-170. Plenum Press, New York. Cottrell, G. A. 1966. Separation and properties of subcellular particles associated with 5-hydroxytryptamine, with acetylcholine and with an unidentified cardio-excitatory substance from Mercenaria NEUROPEPTIDE CARDIOEXCITATION IN MOLLUSCS nervous tissue. Comp. Biochem. Physiol. 17:891907. Cottrell, G. A. and M. Maser. 1967. Subcellular localization of 5-hydroxytryptamine and Substance X in molluscan ganglia. Comp. Biochem. Physiol. 20:901-906. Cottrell, G. A. and N. N. Osborne. 1969. A neurosecretory system terminating in the Helix heart. Comp. Biochem. Physiol. 28:1455-1459. Fernlund, P. 1976. Structure of a light-adapting hormone from the shrimp, Pandalus borealis. Biochim. Biophys. Acta 439:17-25. Fernlund, P. and L. H. Josefsson. 1972. Crustacean color-change hormone: Amino acid sequence and chemical synthesis. Science 177:173-175. Frontali, N. and H. Gainer. 1977. Peptides in invertebrate systems. In H. Gainer (ed.), Peptides in neurobiology, pp. 259-294. Plenum Press, New York. Frontali, N., L. Williams, and J. H. Welsh. 1967. Heart excitatory and inhibitory substances in molluscan ganglia. Comp. Biochem. Physiol. 22:833-841. Gainer, H., Y. P. Loh, and Y. Same. 1977. Biosynthesis of neuronal peptides. In H. Gainer (ed.), Peptides in neurobiology, pp. 183-219. Plenum Press, New York. Greenberg, M. J. 1960. The responses of the Venus heart to catecholamines and high concentrations of 5-hydroxytryptamine. Brit. J. Pharmacol. 15:365374. Greenberg, M. J. 1965. A compendium of responses of bivalve hearts to acetylcholine. Comp. Biochem. Physiol. 14:513-539. Greenberg, M. J. 1969. The role of isoreceptors in neurohormonal regulation of bivalve hearts. In F. 173 Eur. J. Pharmacol. 48:425-430. Hill, R. B. 1958. The effects of certain neurohumors and of other drugs on the ventricle and radula protractor of Busycon canaltculatum and on the ventricle of Strombusgigas. Biol. Bull. 115:471-482. Hill, R. B. and J. W. Sanger. 1974. Anatomy of the innervation and neuromuscular junctions of the radular protractor muscle of the whelk, Busycon canahculatum (L.). Biol. Bull. 147:369-385. Hill, R. B. and J. W. Welsh. 1966. Heart, circulation, and blood cells. In K. M. Wilbur and C. M. Yonge (eds.), Physiology of Mollusca, Vol. 2, pp. 125-174. Academic Press, New York. Ifshin, M., H. Gainer and J. L. Barker. 1975. Peptide factor extracted from molluscan ganglia that modulates bursting pacemaker activity. Nature 254: 72-74. Jaeger, C. P. 1966. Neuroendocrine regulation of cardiac activity in the snail Strophocheilus oblongus. Comp. Biochem. Physiol. 17:409-415. Kleinholz, L. H. 1976. Crustacean neurosecretory hormones and physiological specificity. Amer. Zool. 16:151-166. Kupfermann, I. and K. R. Weiss. 1976. Water regulation by a presumptive hormone contained in identified neurosecretory cell R15 of Aplysia. J. Gen. Physiol. 67:113-123. Leeman, S. E., E. A. Mroz and R. E. Carraway. 1977. Substance P and neurotensin. In H. Gainer (ed.), Peptides in neurobiology, pp. 99-144. Plenum Press, New York. Levitan, I. B. and S. N. Treistman. 1977. Modulation of electrical activity and cyclic nucleotide metabolism in molluscan nervous system by a peptidecontaining nervous system extract. Brain Res. V. McCann (ed.), Comparative physiology of the heart: 136:307-317. Current trends, (Experientia, suppl. 15), pp. 250-265. Burkhauser Verlag, Basel. Mayeri, E. and S. Simon. 1975. Modulation of synaptic transmission and burster neuron activity after Greenberg, M. J., R. A. Agarwal, L. A. Wilkens, and release of a neurohormone in Aplysia. Neurosci. P. J. B. Ligon. 1973. Chemical regulation of rhythAbst. 1:584. mical activity in molluscan muscle. In J. Salanki (ed.), Neurobiology of invertebrates, Tihany 1971 AkadMordue, W. and J. V. Stone. 1977. Relative potencies of locust adipokinetic hormone and prawn red emiai Kiado, Budapest. pigment-concentrating hormone in insect and Grimm-j0rgensen, Y., J. F. McKelvy, and I. M. D. crustacean systems. Gen. Comp. Endocrinol. 33: Jackson. 1975. Immunoreactive thyrotrophin re103-108. leasing factor in gastropod circumoesophageal Nisbet, R. H. and J. M. Plummer. 1966. Further ganglia. Nature 254:620. studies on the fine structure of the heart of AchatHampe, M. M. V., A. Tesch, and C. P.Jaeger. 1969. inidae. Proc. Malac. Soc. Lond. 37:199-208. On the nature of cardio-active substances from Strophocheilus oblongus ganglia. Life Sci. 8:827-835. Nisbet, R. H. and J. M. Plummer. 1969. Functional correlates of fine structure in the heart of AchatHiggins, W. J. 1974. Intracellular actions of 5-hyinidae. In F. V. McCann (ed.), Comparative physiology droxytryptamine on the bivalve myocardium. I. of the heart: Current trends, (Expenentia, Suppl. 15), Adenylate and guanylate cyclases. J. Exp. Zool. pp. 47-68. Burkhauser Verlag, Basel. 190:99-110. Plesch, B. 1977. An ultrastructural study of the inHiggins, W. J. 1977. 5-hydroxytryptamine-induced nervation of the musculature of the pond snail, tachyphylaxis of the molluscan heart and conLymnaea stagnalis (L.) with reference to peripheral comitant desensitization of adenylate cyclase. J. neurosecretion. Cell Tiss. Res. 183:353-369. Cyclic Nucleotide Res. 3:293-302. Price, D. A. and M. J. Greenberg. 1977a. Structure of Higgins, W. J. and M. J. Greenberg. 1974. Intracela molluscan cardioexcitatory neuropeptide. Science lular actions of 5-hydroxytryptamine on the bivalve 197:670-671. myocardium. II. Cyclic nucleotide-dependent Price, D. A. and M. J. Greenberg. 19776. Purification protein kinases and microsomal calcium uptake. J. and characterization of a cardioexcitatory neuroExp. Zool. 190:305-316. peptide from the central ganglia of a bivalve molHiggins, W. J., D. A. Price, and M. J. Greenberg. lusc. Prep. Biochem. 7:261-281. 1978. FMRFamide increases the adenylate cyclase activity and cyclic AMP level of molluscan heart. Ram, J. L. 1977. Hormonal control of reproduction 174 MICHAEL J. GREENBERG AND DAVID A. PRICE in Busycon: Laying of egg capsules caused by nervous system extracts. Biol. Bull. 152:221-232. Ram, J. L., S. R. Salpeter, and W. J. Davis. 1977. Pleurobranchaea egg-laying hormone: Localization and partial purification. J. Comp. Physiol. B 119: 171-194. Robberecht, P., M. Deschodt-Lanckman and J. J. Vanderhaeghen. 1978. Demonstration of biological activity of brain gastrin-like peptidic material in the human: Its relationship with the COOH-terminal octapeptide of cholecystokinin. Proc. Natl. Acad. Sci. U. S. A. 75:524-528. Sathananthan, A. H. and G. Burnstock. 1976. Evidence for a non-cholinergic, non-aminergic innervation of the venus clam heart. Comp. Biochem. Physiol. 550:111-118. Simantov, R., R. Goodman, D. Aposhian, and S. H. Snyder. 1976. Phylogenetic distribution of a morphine-like peptide 'enkephalin.' Brain Res. I l l : 204-211. Simpson, L. 1969. Morphological studies of possible neuroendocrine structures in Helisoma tenue (Gastropoda: Pulmonata). Z. Zellforsch. 102:570-593. Skelley, D. S., L. P. Brown, and P. K. Besch. 1973. Radioimmunoassay. Clin. Chem. 19:146-186. Starratt, A. N. and B. E. Brown. 1975. Structure of the pentapeptide proctolin, a proposed neurotransmitter in insects. Life Sci. 17:1253-1256. Stone, J. V., W. Mordue, K. E. Batley, and H. R. Morris. 1976. Structure of locust adipokinetic hormone, a neurohormone that regulates lipid utilization during flight. Nature 263:207-211. Straus, E., R. S. Yalow, and H. Gainer. 1975. Molluscan gastrin: Concentration and molecular forms. Science 190:687-688. Taraskevich, P. S. and W. W. Douglas. 1977. Action potentials occur in cells of the normal anterior pituitary gland and are stimulated by the hypophysiotropic peptide thyrotropin-releasing hormone. Proc. Natl. Acad. Sci. U.S.A. 74:4064-4067. Toevs, L. A. and R. W. Brackenbury. 1969. Bag cellspecific proteins and the humoral control of egg laying in Aptysia californica. Comp. Biochem. Physiol. 29:207-216. Treistman, S. N. and I. B. Levitan. 1976. Alteration of electrical activity in molluscan neurones by cyclic nucleotides and peptide factors. Nature 261:62-64. Twarog, B. M. 1976. Aspects of smooth muscle function in molluscan catch muscle. Current Topics Physiol. 56:829-838. Vanderhaeghen, J. J., J. C. Signeau, and W. Gepts. 1975. New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature 257:604-605. Wallis, M. 1975. The molecular evolution of pituitary hormones. Biol. Rev. 50:35-98. Welsh, J. H. 1955. Neurohormones. In G. Pincus and K. V. Thimann (eds.), The hormones, pp. 98-151. Academic Press, New York. Welsh, J. H. and R. Taub. 1948. The action of choline and related compounds on the heart of Venus mercenaria. Biol. Bull. 95:346-353. Wilkens, L. A. and M. J. Greenberg. 1973. Effects of acetylcholine and 5-hydroxytryptamine and their ionic mechanisms of action on the electrical and mechanical activity of molluscan heart smooth muscle. Comp. Biochem. Physiol. 45A:637-651. Zetler, G. 1976. The peptidergic neuron: A working hypothesis. Biochem. Pharmacol. 25:1817-1818.